The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Recurrent Clostridium difficile infection: A review of risk factors, treatments, and outcomes
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zar, F. A., Bakkanagari, S. R., Moorthi, K. M. L. S. T., & Davis, M. B. (2007) · Clinical Infectious Diseases · doi:10.1086/519265 · Cited by 1,252
Decreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010
Pepin, J., Saheb, N., Coulombe, M.-A., Alary, M.-E., Corriveau, M.-P., Authier, S., Leblanc, M., Rivard, G., Bettez, M., Primeau, V., et al. (2005) · Clinical Infectious Diseases · doi:10.1086/496986 · Cited by 995
Asymptomatic Carriage of Clostridium difficile and Serum Levels of IgG Antibody against Toxin A
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420604 · Cited by 935
McFarland, L. V. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03510480037031 · Cited by 857
Kyne, L., Warny, M., Qamar, A., & Kelly, C. P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03592-3 · Cited by 804
Clostridium difficile Infection in Patients Discharged from US Short-stay Hospitals, 1996–20031
McDonald, L. C., Owings, M., & Jernigan, D. B. (2006) · Emerging Infectious Diseases · doi:10.3201/eid1203.051064 · Cited by 788
Teasley, D., Olson, M., Gebhard, R., Gerding, D., Peterson, L., Schwartz, M., & Lee, J. (1983) · The Lancet · doi:10.1016/s0140-6736(83)91036-x · Cited by 785
Breaking The Cycle: Treatment Strategies for 163 Cases of Recurrent Clostridium Difficile Disease
McFarland, L. V., Elmer, G. W., & Surawicz, C. M. (2002) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05839.x · Cited by 724
Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
Pepin, J., Alary, M.-E., Valiquette, L., Raiche, E., Ruel, J., Fulop, K., Godin, D., & Bourassa, C. (2005) · Clinical Infectious Diseases · doi:10.1086/430315 · Cited by 570
Surawicz, C. M., McFarland, L. V., Greenberg, R. N., Rubin, M., Fekety, R., Mulligan, M. E., Garcia, R. J., Brandmarker, S., Bowen, K., Borjal, D., et al. (2000) · Clinical Infectious Diseases · doi:10.1086/318130 · Cited by 529
Clinical Recognition and Diagnosis of Clostridium difficile Infection
Bartlett, J. G., & Gerding, D. N. (2008) · Clinical Infectious Diseases · doi:10.1086/521863 · Cited by 527
Aas, J., Gessert, C. E., & Bakken, J. S. (2003) · Clinical Infectious Diseases · doi:10.1086/367657 · Cited by 518
Wenisch, C., Parschalk, B., Hasenhundl, M., Hirschl, A. M., & Graninger, W. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.5.813 · Cited by 505
Relatively Poor Outcome after Treatment of Clostridium difficile Colitis with Metronidazole
Musher, D. M., Aslam, S., Logan, N., Nallacheru, S., Bhaila, I., Borchert, F., & Hamill, R. J. (2005) · Clinical Infectious Diseases · doi:10.1086/430311 · Cited by 504
Meta-analysis to assess risk factors for recurrent Clostridium difficile infection
Garey, K. W., Sethi, S., Yadav, Y., & DuPont, H. L. (2008) · Journal of Hospital Infection · doi:10.1016/j.jhin.2008.08.012 · Cited by 376
Treatment of Clostridium difficile-associated disease: old therapies and new strategies
Aslam, S., Hamill, R. J., & Musher, D. M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70215-2 · Cited by 366
Bauer, M. P., Kuijper, E. J., & van Dissel, J. T. (2009) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2009.03099.x · Cited by 366
Epidemiology of Recurrences or Reinfections of Clostridium difficile -Associated Diarrhea
Barbut, F., Richard, A., Hamadi, K., Chomette, V., Burghoffer, B., & Petit, J.-C. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.6.2386-2388.2000 · Cited by 355
Recurrent Clostridium Difficile Disease: Epidemiology and Clinical Characteristics
McFarland, L. V., Surawicz, C. M., Rubin, M., Fekety, R., Elmer, G. W., & Greenberg, R. N. (1999) · Infection Control & Hospital Epidemiology · doi:10.1086/501553 · Cited by 353
Johnson, S., Schriever, C., Galang, M., Kelly, C. P., & Gerding, D. N. (2007) · Clinical Infectious Diseases · doi:10.1086/511870 · Cited by 312
Self-citationEnvironmental Control to Reduce Transmission of Clostridium difficile
Mayfield, J. L., Leet, T., Miller, J., & Mundy, L. M. (2000) · Clinical Infectious Diseases · doi:10.1086/318149 · Cited by 279
&NA; (2006) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000202057.19407.4d · Cited by 271
Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrhea
Sougioultzis, S., Kyne, L., Drudy, D., Keates, S., Maroo, S., Pothoulakis, C., Giannasca, P. J., Lee, C. K., Warny, M., Monath, T. P., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.004 · Cited by 260
Pepin, J., Routhier, S., Gagnon, S., & Brazeau, I. (2006) · Clinical Infectious Diseases · doi:10.1086/501126 · Cited by 246
Muto, C. A., Blank, M. K., Marsh, J. W., Vergis, E. N., O'Leary, M. M., Shutt, K. A., Pasculle, A. W., Pokrywka, M., Garcia, J. G., Posey, K., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/522654 · Cited by 241
Human antibody response to Clostridium difficile toxin A in relation to clinical course of infection
Warny, M., Vaerman, J. P., Avesani, V, & Delmée, M. (1994) · Infection and Immunity · doi:10.1128/iai.62.2.384-389.1994 · Cited by 230
Wullt, M., Hagslätt, M.-L. J., & Odenholt, I. (2003) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540310010985 · Cited by 221
Wilcox, M. H. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh176 · Cited by 200
Diarrhea Etiology in a Children’s Hospital Emergency Department: A Prospective Cohort Study
Klein, E. J., Boster, D. R., Stapp, J. R., Wells, J. G., Qin, X., Clausen, C. R., Swerdlow, D. L., Braden, C. R., & Tarr, P. I. (2006) · Clinical Infectious Diseases · doi:10.1086/507335 · Cited by 193
Louie, T. J., Emery, J., Krulicki, W., Byrne, B., & Mah, M. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01443-07 · Cited by 190
Rifampin and Rifaximin Resistance in Clinical Isolates of Clostridium difficile
O'Connor, J. R., Galang, M. A., Sambol, S. P., Hecht, D. W., Vedantam, G., Gerding, D. N., & Johnson, S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00342-08 · Cited by 187
Self-citationIn Vitro Activity and Fecal Concentration of Rifaximin after Oral Administration
Jiang, Z.-D., Ke, S., Palazzini, E., Riopel, L., & Dupont, H. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2205-2206.2000 · Cited by 182
Recurrence of symptoms in Clostridium difficile infection—relapse or reinfection?
Wilcox, M. H., Fawley, W. N., Settle, C. D., & Davidson, A. (1998) · Journal of Hospital Infection · doi:10.1016/s0195-6701(98)90062-7 · Cited by 175
Recurrences of Clostridium difficile Diarrhea Not Caused by the Original Infecting Organism
Johnson, S., Adelmann, A., Clabots, C. R., Peterson, L. R., & Gerding, D. N. (1989) · Journal of Infectious Diseases · doi:10.1093/infdis/159.2.340 · Cited by 163
Self-citationCurry, S. R., Marsh, J. W., Shutt, K. A., Muto, C. A., O’Leary, M. M., Saul, M. I., Pasculle, A. W., & Harrison, L. H. (2009) · Clinical Infectious Diseases · doi:10.1086/596315 · Cited by 156
Update on the changing epidemiology of Clostridium difficile-associated disease
McFarland, L. V. (2008) · Nature Clinical Practice Gastroenterology & Hepatology · doi:10.1038/ncpgasthep1029 · Cited by 149
Clinical impact and associated costs of Clostridium difficile- associated disease
Spencer, R. C. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/41.suppl_3.5 · Cited by 127
Buggy, B. P., Fekety, R., & Silva, J. (1987) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-198704000-00009 · Cited by 123
Musher, D. M., Logan, N. D., Mehendiratta, V., Melgarejo, N. A., Garud, S. S., & Hamill, R. J. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkl553 · Cited by 123
Clostridium difficile–associated diarrhea: an emerging threat to pregnant women
Rouphael, N., O’Donnell, J. A., Bhatnagar, J., Lewis, F. M. T., Polgreen, P. M., Beekmann, S. E., Guarner, J., Killgore, G., Coffman, B., Campbell, J., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.062 · Cited by 119
Lagrotteria, D. D., Holmes, S., Smieja, M., Smaill, F., & Lee, C. (2006) · Clinical Infectious Diseases · doi:10.1086/506354 · Cited by 118
Louie, T., Miller, M., Donskey, C. J., Mullane, K. M., & Goldstein, E. J. C. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01442-07 · Cited by 112
Relapse versus reinfection withClostridium difficile
O'Neill, G. L., Beaman, M. H., & Riley, T. V. (1991) · Epidemiology and Infection · doi:10.1017/s0950268800049323 · Cited by 111
In Vitro Activity of OPT-80 against Clostridium difficile
Ackermann, G., Löffler, B., Adler, D., & Rodloff, A. C. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.6.2280-2282.2004 · Cited by 110
Pediatric Clostridium difficile: A Phantom Menace or Clinical Reality?
McFarland, L. V., Brandmarker, S. A., & Guandalini, S. (2000) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/00005176-200009000-00004 · Cited by 104
GT160-246, a Toxin Binding Polymer for Treatment of Clostridium difficile Colitis
Kurtz, C. B., Cannon, E. P., Brezzani, A., Pitruzzello, M. C., Dinardo, C., Rinard, E., Acheson, D. W. K., Fitzpatrick, R., Kelly, P. J., Shackett, K., et al. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.8.2340-2347.2001 · Cited by 90
Tang-Feldman, Y. J., Mayo, S. L., Joseph Silva, & Cohen, S. H. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.7.3413-3414.2003 · Cited by 67
Kokkotou, E. G., Moss, A. C., Michos, A. G., Espinoza, D., Cloud, J. W., Mustafa, N., O’Brien, M. J., Pothoulakis, C., & Kelly, C. P. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01143-07 · Cited by 51
Moncino, M. D., & Falletta, J. M. (1992) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199211000-00015 · Cited by 48
Peripartum Clostridium difficile infection: case series and review of the literature
Garey, K. W., Jiang, Z., Yadav, Y., Mullins, B. C., Wong, K., & DuPont, H. L. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.05.001 · Cited by 44
Gogate, A., De, A., Nanivadekar, R., Mathur, M., Saraswathi, K., Jog, A. S., & Kulkarni, M. (2005) · PubMed · Cited by 43
Graf, C. E., & Gavazzi, G. (2006) · Journal of Infection · doi:10.1016/j.jinf.2006.01.019 · Cited by 38
Pruksananonda, P., & Powell, K. R. (1989) · PubMed · Cited by 32
Sanchez, J. L., Gerding, D. N., Olson, M. M., et al. (1999) · Anaerobe · doi:10.1006/anae.1999.0268 · Cited by 22
Diagnostic and treatment delays in recurrent clostridium difficile–associated disease
Scheurer, D. B. (2008) · Journal of Hospital Medicine · doi:10.1002/jhm.277 · Cited by 19
Cited by
Gough, E., Shaikh, H., & Manges, A. R. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir632 · Cited by 1,003
Treatment of First Recurrence of Clostridium difficile Infection: Fidaxomicin Versus Vancomycin
Cornely, O. A., Miller, M. A., Louie, T. J., Crook, D. W., & Gorbach, S. L. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis462 · Cited by 401
Can we identify patients at high risk of recurrent Clostridium difficile infection?
Kelly, C. P. (2012) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12046 · Cited by 396
Ferreyra, J. A., Wu, K. J., Hryckowian, A. J., Bouley, D. M., Weimer, B. C., & Sonnenburg, J. L. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.11.003 · Cited by 378
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review
Drekonja, D., Reich, J., Gezahegn, S., Greer, N., Shaukat, A., MacDonald, R., Rutks, I., & Wilt, T. J. (2015) · Annals of Internal Medicine · doi:10.7326/m14-2693 · Cited by 371
Metadata
- Authors
- Johnson, S.
- Venue
- Journal of Infection
- Publisher
- Elsevier BV
- Published
- 2009-06
- Volume
- 58
- Issue
- 6
- Pages
- 403-410
- ISSN
- 0163-4453 (ISSN-L)
- OpenAlex
- W2089018302
- Cited by
- 397
- References
- 56
- FWCI
- 16.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.